Search

Your search keyword '"Dulou, Renaud"' showing total 32 results
Start Over Author "Dulou, Renaud"
32 results on '"Dulou, Renaud"'

10. Deployment of the Surgical Life-saving Module (SLM) in 2017: Lessons learned in setting up and training operational surgical units

Author

Malgras, Brice, primary, Aoun, Olivier, additional, Pauleau, Ghislain, additional, Boddaert, Guillaume, additional, Hornez, Emmanuel, additional, Dulou, Renaud, additional, Delmas, Jean-Marc, additional, Haen, Pierre, additional, Laversanne, Sophie, additional, Crambert, Anna, additional, and Balandraud, Paul, additional

Published
2019
Full Text
View/download PDF

12. Expérience monocentrique d’un traitement par bévacizumab dans la prise en charge des glioblastomes récidivant

Author

Mbagui, Rodrigue, primary, Ricard, Damien, additional, Vallard, Alexis, additional, Magne, Nicolas, additional, Dulou, Renaud, additional, Lahutte, Marion, additional, Calcina, Philippe, additional, Taillia, Hervé, additional, Yordanova, Yordanka, additional, Delmas, Jean-Marc, additional, Bauduceau, Olivier, additional, and Chargari, Cyrus, additional

Published
2016
Full Text
View/download PDF

13. Severe Vertex Epidural Hematoma in a Child: A Case Report of a Management without Expert Neurosurgical Care

Author

Brévart, Christophe, Bertani, Antoine, Abdourahman Aden, Hassan, Menguy, Paul, and Dulou, Renaud

Subjects
Article Subject
Abstract

Vertex epidural hematomas (VEDHs) are an uncommon situation and difficulties may be encountered in their diagnosis and management. This is more complicated when the surgical management has to be performed by general surgeons, not specialized in neurosurgery, in a remote location. It was in this context that we were brought to care in charge a 2-year-old boy who required a neurosurgical emergency rescue for a severe VEDH in Djibouti. Through the description of this case, we want to emphasize the value of developing a network of teleconsultation for the benefit of remote and isolated locations and learning basic techniques of emergency neurosurgery.

Published
2011
Full Text
View/download PDF

15. Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy

Author

Mbagui, Rodrigue, primary, Langrand-Escure, Julien, additional, Annede, Pierre, additional, Mery, Benoite, additional, Ceccaldi, Bernard, additional, Guy, Jean-Baptiste, additional, Falk, Alexander T., additional, Bauduceau, Olivier, additional, Bosacki, Claire, additional, Jacob, Julian, additional, Helissey, Carole, additional, Ferrand, Francois-Regis, additional, Dulou, Renaud, additional, Le Moulec, Sylvestre, additional, Vedrine, Lionnel, additional, Magné, Nicolas, additional, and Chargari, Cyrus, additional

Published
2015
Full Text
View/download PDF

17. First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma

Author

Chargari, Cyrus, primary, Pacaut, Cécile, additional, Le Moulec, Sylvestre, additional, Moriceau, Guillaume, additional, Moussaid, Yassine, additional, Rivoirard, Romain, additional, Dulou, Renaud, additional, Jacob, Julian, additional, Guy, Jean-Baptiste, additional, Bauduceau, Olivier, additional, Ceccaldi, Bernard, additional, Védrine, Lionel, additional, Fournel, Pierre, additional, and Magné, Nicolas, additional

Published
2013
Full Text
View/download PDF

21. The French mobile neurosurgical unit

Author

Dulou, Renaud, primary, Dagain, Arnaud, additional, Delmas, Jean-Marc, additional, Lambert, Evelyne, additional, Blondet, Eric, additional, Goasguen, Olivier, additional, Pouit, Bruno, additional, Dutertre, Guillaume, additional, de Soultrait, François, additional, and Pernot, Philippe, additional

Published
2010
Full Text
View/download PDF

27. Management of War-Related Ballistic Craniocerebral Injuries in a French Role 3 Hospital During the Afghan Campaign.

Author

Joubert, Christophe, Sellier, Aurore, Desse, Nicolas, Dagain, Arnaud, Pernot, Philippe, Dulou, Renaud, Aoun, Olivier, Roqueplo, Cédric, Bordes, Julien, Esnault, Pierre, Delmas, Jean-Marc, and Fouet, Mathilde

Subjects
*CRANIOCEREBRAL injuries, *BRAIN injury treatment, *WAR casualties, *EPIDEMIOLOGY, *HEALTH outcome assessment, *HEMODYNAMICS, *MEDICAL care, *ARMED Forces
Abstract

Introduction France deployed to Afghanistan from 2001 to 2014 within the International Security and Assistance Force. A French role 3 hospital was built in 2009 in the vicinity of Kabul International Airport (KaIA). The objectives of this study were to describe the epidemiology, management, and outcome of war-related craniocerebral injuries during the Afghan campaign in a French role 3 hospital. Methods From March 1, 2010 to September 30, 2012, we conducted a retrospective descriptive study in Kabul, Afghanistan. All patients presenting with a ballistic craniocerebral injury to the KaIA role 3 hospital were included. Results We analyzed 48 records. Mean age was 21.9 years (1–46 years) with a 37:11 (male:female) sex ratio and a majority Afghan population ( n = 41). Civilians represented 64.6% ( n = 31) of casualties. On the battlefield, mean Glasgow Coma Scale score was 9.4 [3–15]. On arrival at the KaIA field hospital, 20 of the 48 patients were hemodynamically unstable. All patients underwent a full-body computed tomography scan. The majority of our casualties had associated injuries. Neurosurgery was indicated for 42 (87.5%) patients. The surgery consisted of wound debridement plane by plane associated with decompressive craniectomy ( n = 11), debridement craniectomy ( n = 19), and craniotomy ( n = 12). A total of 32.4% wounded died at the point of injury, 8.4% at the emergency department, and 16.9% after surgery. Conclusions War casualties with ballistic head injuries were predominantly multitraumatized patients with hemodynamic compromise requiring neurosurgical damage control management and multidisciplinary care. The neurosurgeon has thus an essential role to play. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

28. [Single center experience with bevacizumab in a cohort of patients treated for a relapsing glioblastoma].

Author

Mbagui R, Ricard D, Vallard A, Magne N, Dulou R, Lahutte M, Calcina P, Taillia H, Yordanova Y, Delmas JM, Bauduceau O, and Chargari C

Subjects
Adult, Aged, Female, Glioblastoma mortality, Humans, Male, Middle Aged, Neoplasm Recurrence, Local mortality, Retrospective Studies, Survival Rate, Young Adult, Angiogenesis Inhibitors therapeutic use, Bevacizumab therapeutic use, Glioblastoma drug therapy, Neoplasm Recurrence, Local drug therapy
Abstract

Purpose: Although there is no standard treatment for recurrent glioblastoma, prospective data in selected patients have suggested the usefulness of bevacizumab. We report our single center experience with bevacizumab in a cohort of patients treated for a relapsing glioblastoma., Methods: We performed a retrospective analysis of consecutive patients treated with bevacizumab for a relapsed glioblastoma, between 2008 and 2013. Tumor responses, toxicities, time to progression and overall survival rates were analyzed., Results: Thirty-five consecutive patients were identified. They were treated with bevacizumab 10mg/kg biweekly, associated with irinotecan (n=29; 84%), temozolomide (n=3; 9%) or as single agent (n=3; 9%) for a glioblastoma relapsing after chemoradiation (n=29) or after first line temozolomide only because of a poor general health status or because of multifocal tumor. Two (6%), 28 (80%) and five (14%) patients presented with Recursive Partitioning Analysis (RPA) III, IV and V-VI, respectively. After 2-3 months of treatment, median dose of prednisolone per patient was decreased three times. Clinical improvements or stability were reported in eight (23%) and 17 patients (49%). The best tumor response was partial response in 14 patients (40%), stable disease in nine patients (26%) and tumor progression in 11 patients (31%). Toxicities requiring treatment disruption were reported in five patients (14%). Median survival was 18.4 months (5-41 months). Median time interval between bevacizumab initiation and its disruption because of clinical/radiological progression and/or toxicity was 5.0 months (0.6-21.4 months). Median survival from bevacizumab initiation was 8.1 months (1.4-34 months)., Conclusion: This single center retrospective experience suggests that bevacizumab is active for recurrent glioblastoma, in a series of poorly selected patients. Median survival times were in the range of those reported in therapeutic trials. This study questions the validity of usual predictive factors in the era of bevacizumab., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)

Published
2016
Full Text
View/download PDF

29. [Multiple cerebral abscesses secondary to a dental infection].

Author

Fouet M, Brau JJ, Dimitriu C, Kané A, Dulou R, and Yordanova Y

Subjects
Adult, Brain Abscess pathology, Humans, Magnetic Resonance Imaging, Male, Brain Abscess microbiology, Periapical Granuloma microbiology, Staphylococcal Infections complications
Published
2014

30. [Your images. Post traumatic cervical epidural hematoma].

Author

Dulou L, Malgras B, Dagain A, and Dulou R

Subjects
Accidental Falls, Aged, Cervical Vertebrae pathology, Elevators and Escalators, Female, Hematoma, Epidural, Spinal etiology, Humans, Magnetic Resonance Imaging, Spinal Fractures pathology, Tomography, X-Ray Computed, Cervical Vertebrae injuries, Hematoma, Epidural, Spinal pathology, Spinal Fractures complications
Published
2010

31. [Cervical dislocation: diagnostic pitfalls].

Author

Dulou R, Dagain A, Dutertre G, and Pernot P

Subjects
Accidental Falls, Aged, Cervical Vertebrae diagnostic imaging, Cervical Vertebrae surgery, Humans, Joint Dislocations surgery, Male, Radiography, Cervical Vertebrae injuries, Joint Dislocations diagnosis
Published
2009

32. [Intracranial hypotensin].

Author

Dulou R, Dagain A, Taillia H, and Pernot P

Subjects
Contrast Media, Female, Gadolinium, Humans, Middle Aged, Intracranial Hypotension diagnosis, Magnetic Resonance Imaging
Published
2008

Catalog

Books, media, physical & digital resources
See catalog results